BlackRock cuts ChemoMetec share voting below 15%, total stays at 15.08%
BlackRock lowered voting rights attached to ChemoMetec shares to 14.97%, while instrument-based voting rose to 0.11%. Aggregate voting rights remain unchanged at 15.08%.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
ChemoMetec A/S (CHEMM) reported, citing GlobeNewswire, that BlackRock reduced voting rights attached to its shares to 14.97% as of October 15. That level took the holding below the 15% regulatory threshold.
At the same time, voting rights held through financial instruments rose to 0.11%. The aggregate stake stayed at 15.08%, so BlackRock's overall influence over the company did not change. The change is dated October 15, 2026.
why it matters
This is a technical ownership disclosure: part of the voting power moved from shares to derivative instruments without changing the total stake. For the market, such a shift is usually minor unless the aggregate holding starts to move meaningfully or a major shareholder takes a more active stance.
tags
instruments
sources
- ChemoMetec A/S (CHEMM): BlackRock Share Voting Falls Below 15%; Total Still 15.08% — globenewswire.com, 21 October 2026 at 18:42 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗